Skip to main content
Premium Trial:

Request an Annual Quote

Welcome to Information Overload

Daniel MacArthur at Genetic Future has a post about whether there will be value in sequencing the full genome of each newborn in the next decade. "There are plenty of very rare, severe disease mutations that would be clinically useful to detect at an early stage," he writes. "Secondly, pharmacogenomics is finally coming of age." He notes that advances from GWAS have begun to make the PGx field more viable, citing abacavir and statins as examples of drugs that can be kept away from patients who will have major adverse reactions "by typing a single genetic marker."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.